Global Precision Medicine Market Research Report – Forecast to 2022

Global Precision Medicine Market Research Report – Forecast to 2022

ID: MRFR/Pharma/0420-CRR | March, 2017 | Region: Global | 313 pages | Cooked Research Reports

Global Precision Medicine market Information, By Ecosystem (pharma & biotech companies, diagnostic tool companies, healthcare IT/ big data companies, clinical laboratories), By Sub-markets (companion diagnostics, biomarker-based test, targeted therapeutics, pharmacogenomics, molecular diagnostics, others), By Therapeutics (cancer/oncology, cardiovascular disease, central nervous system, infectious diseases, others) - Forecast to 2022


Market Synopsis of Global Precision Medicine Market:
Market Scenario:
Precision medicine refers to medicines developed as per an individual’s genetic profile that helps as a guide for the prevention, diagnosis and treatment of diseases. The global precision medicine market was valued at $38.92 billion in 2015, and is expected to reach $88.64 billion by 2022. Thus the market is expected to perform a growth at a CAGR of 12.48% from 2015 to 2022.

The major market driving factor for precision medicine are patient’s involvement in personal healthcare, integration of wireless technologies with portable healthcare devices, and increase in genetic diseases (due to mutation, UV rays) among others.

The market constraints include potential threat to personal data, high diagnostic cost as a barrier, potential risk of hardware or software failure, stringent regulations and standards, lack of awareness about the possible applications of precision medicine, reimbursement policies and regulatory framework, limited knowledge about the application of test and techniques, lack of research and evidences creating hindrances in its application.


Study Objectives Global Precision Medicine Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global precision medicine market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by ecosystem (pharma & biotech companies, diagnostic tool companies, healthcare it/ big data companies, clinical laboratories), by sub-markets (companion diagnostics, biomarker-based test, targeted therapeutics, pharmacogenomics, molecular diagnostics, others), by therapeutics (cancer/oncology, cardiovascular disease, central nervous system, infectious diseases, others)

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.


Global Precision Medicine Market, by Region 2015 & 2022 (USD million)


 Global Precision Medicine Market, by Region 2015 & 2022 (USD million) 


Intended Audience:



  • Global Precision Medicine manufacturers

  • Global Precision Medicine suppliers

  • Research and Development Laboratories

  • Market Research and Consulting Service Providers


Key Finding:



  • The global precision medicine market is expected to reach USD 88.64 billion by 2022.

  • By ecosystem diagnostic tool companies holds the largest market share of precision medicine market and is expected to reach USD 27.56 billion by 2022.

  • By sub-market, company diagnostics holds the largest market share of precision medicine market and is expected to reach USD 21.32 billion by 2022.


Key Players for Global Precision Medicine Market:
Abbott Laboratories, Almac Group, Ltd., Asuragen, Inc., Biomérieux Sa, Cepheid Inc., Cetics Healthcare Technologies Gmbh, Ge Healthcare, Glaxosmithkline Plc, Johnson & Johnson, Laboratory Corporation Of America Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen, Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ab-Biotics Sa, Caris Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh, Precision For Medicine


Segments:
Global Precision Medicine market has been segmented on the basis of ecosystem, sub-market, therapeutics and region.


Regional Analysis of Global Precision Medicine Market:
Globally North America is the largest market for global precision medicine. Europe is the second-largest market for global precision medicine. The near future market for precision medicine will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future.

The report for Global Precision Medicine Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

1.1 Scope Of The Study


1.2 Precision Medicine: Report Coverage


1.3 Research Methodology


1.3.1 Research Methodology For The Global Market Study





1.3.2 Global Precision Medicine: Research Methodology


1.3.3 Key Data Point Sources




1.4 Report Description


3.1 Introduction


3.2 Market Timeline


3.3 Key Participants, Strategies & Developments


3.3.1 Government Agencies


3.3.2 Academic Institutions


3.3.3 Device & Service Providers


3.4 Key Market Strategies And Developments


3.4.1 Introduction


3.4.2 Partnerships, Agreements, And Collaborations


3.4.3 Mergers & Acquisitions


3.4.4 Product Development And Launch


3.4.5 Business Expansion/Contracts


3.4.6 Patents, Approvals And Certifications


3.4.7 Others (Events & Recognitions)

4.1 Introduction


4.2 Market Drivers


4.2.1 Patients Involvement In Personal Healthcare


4.2.2 Technologies Driving The Market (E.G. Next-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)


4.2.3 Increase In Genetic Diseases


4.2.4 Potential For More Targeted Therapies


4.2.5 Integration Of Big Data Healthcare Companies With Pharma & Biotech Companies


4.3 Market Challenges


4.3.1 Potential Threat To Personal Data


4.3.2 High Diagnostic Cost As A Barrier


4.3.3 Potential Risk Of Hardware Or Software Failure


4.3.4 Stringent Regulations And Standards


4.3.5 Lack Of Awareness About The Possible Applications Of Precision Medicine


4.3.6 Reimbursement Policies And Regulatory Framework


4.3.7 Limited Knowledge About The Application Of Test And Techniques


4.3.8 Lack Of Research And Evidences Creating Hindrances In Its Application


4.4 Market Opportunities


4.4.1 Introduction Of Precision Medicine Solutions In Developing Economies


4.4.2 Downsizing The Cost Of Genome Sequencing To Three Digits

5.1 Value Chain Analysis


5.1.1 Device Manufacturer & Drug Producers


5.1.2 Healthcare Providers


5.1.3 Healthcare Its Or Big Data Companies


5.1.4 Regulators


5.1.5 Third Party Payers


5.1.6 Patients


5.2 Porter Five Force Analysis


5.2.1 Bargaining Power Of Buyer (Patient)


5.2.2 Bargaining Power Of Supplier


5.2.3 Threat From Substitute


5.2.4 Threat From A New Entrant


5.2.5 Intensity Of Competitive Rivalry

6.1 Introduction


6.1.1 Regulatory Bodies






6.1.2 Consortiums


6.1.3 Alliances/Associations

7.1 Introduction


7.1.1 Market Statistics


7.2 Pharmaceuticals And Biotechnology Companies


7.2.1 Key Market Trends, Developments And Participants





7.3 Diagnostic Companies


7.3.1 Key Market Trends, Developments And Participants





7.4 Healthcare It Specialists/ Big Data Companies


7.4.1 Key Market Trends, Developments And Participants





7.5 Clinical Laboratories


7.5.1 Key Market Trends, Developments And Participants




8.1 Introduction


8.1.1 Market Statistics


8.2 Companion Diagnostics


8.3 Biomarker-Based Test


8.3.1 Role Of Biobanking Into Biomarker


8.3.2 Key Participants


8.4 Targeted Therapeutics


8.4.1 Key Participants


8.5 Pharmacogenomics (Pgx)


8.5.1 Key Market Trends, Developments And Participants





8.6 Molecular Diagnostics


8.7 Others


8.7.1 Next-Generation Sequencing


8.7.2 Consumer Genomics



8.7.3 3d Printing


8.7.4 Prosthetics Market


8.7.5 Human Tissues Market

9.1 Introduction


9.1.1 Market Statistics


9.2 Cancer/Oncology


9.2.1 Market Statistics


9.2.2 Types Of Cancer


9.2.3 Drugs & Tests


9.2.4 Key Market Trends, Developments & Participants





9.3 Cardiovascular Disease (Cvd)


9.3.1 Market Statistics


9.3.2 Drugs & Tests


9.3.3 Market Trends & Market Developments





9.4 Central Nervous System


9.4.1 Market Statistics


9.4.2 Neurological



9.4.3 Psychiatric Disorders



9.4.4 Market Tends & Market Developments





9.5 Infectious Diseases


9.5.1 Market Statistics


9.5.2 Infectious Diseases Drugs & Tests


9.5.3 Market Developments & Participants




9.6 Others


9.6.1 Market Statistics


9.6.2 Market Trends, Developments & Participants




10.1 Introduction


10.1.1 Market Statistics


10.2 The Americas


10.2.1 North America










10.2.2 South America






10.3 Europe


10.3.1 Key Market Trends, Developments And Participants





10.4 Asia-Pacific (Apac)


10.4.1 Key Market Trends, Developments And Participants




10.5 Rest Of The World/Midde East & Africa (Mea)


10.5.1 Africa



10.5.2 Key Market Developments And Participants



11.1 Abbott Laboratories


11.1.1 Overview


11.1.2 Financials






11.1.3 Swot Analysis


11.2 Almac Group, Ltd.


11.2.1 Overview


11.2.2 Financials


11.2.3 Key Developments


11.2.4 Swot Analysis


11.3 Asuragen, Inc.


11.3.1 Overview


11.3.2 Financials


11.3.3 Key Developments


11.3.4 Swot Analysis


11.4 Biomérieux Sa


11.4.1 Overview


11.4.2 Financials





11.4.3 Key Developments


11.4.4 Swot Analysis


11.5 Cepheid Inc.


11.5.1 Overview


11.5.2 Financials





11.5.3 Key Developments


11.5.4 Swot Analysis


11.6 Cetics Healthcare Technologies Gmbh


11.6.1 Overview


11.6.2 Financials


11.6.3 Key Developments


11.6.4 Swot Analysis


11.7 Ge Healthcare


11.7.1 Overview


11.7.2 Financials





11.7.3 Key Developments


11.8 Glaxosmithkline Plc (Gsk)


11.8.1 Overview


11.8.2 Financials






11.9 Intomics A/S


11.9.1 Overview


11.9.2 Financials


11.9.3 Key Developments


11.9.4 Swot Analysis


11.10 Johnson & Johnson


11.10.1 Overview


11.10.2 Financials





11.10.3 Key Developments


11.11 Laboratory Corporation Of America Holdings


11.11.1 Overview


11.11.2 Financials




11.11.3 Key Developments


11.11.4 Swot Analysis


11.12 Medtronic


11.12.1 Overview


11.12.2 Financials



11.12.3 Key Developments


11.13 Novartis


11.13.1 Overview


11.13.2 Financials





11.14 Pfizer Inc.


11.14.1 Overview


11.14.2 Financials





11.14.3 Key Developments


11.14.4 Swot Analysis


11.15 Qiagen


11.15.1 Overview


11.16 Biobase Gmbh (Subsidiary)


11.16.1 Overview


11.16.2 Financials



11.16.3 Key Developments (Biobase)


11.17 Quest Diagnostics Inc


11.17.1 Overview


11.17.2 Financials




11.17.3 Key Developments


11.17.4 Swot Analysis


11.18 Randox Laboratories Ltd.


11.18.1 Overview


11.18.2 Financials


11.18.3 Key Developments


11.18.4 Swot Analysis


11.19 Roche Holding Ag-Br


11.19.1 Overview


11.19.2 Financials




11.19.3 Key Developments


11.19.4 Swot Analysis


11.20 Sanofi Pharma


11.20.1 Overview


11.20.2 Financials




11.21 Takeda Pharmaceutical Company Limited


11.21.1 Overview


11.21.2 Financials



11.21.3 Key Developments


11.21.4 Swot Analysis


11.22 Teva Pharmaceutical Industries Ltd.


11.22.1 Overview


11.22.2 Financials





11.22.3 Key Developments


11.22.4 Swot Analysis


11.23 Ab-Biotics Sa


11.23.1 Overview


11.24 Caris Life Sciences


11.24.1 Overview


11.25 Healthcore, Inc.


11.25.1 Overview


11.26 Ibm


11.26.1 Overview


11.27 Innventis


11.27.1 Overview


11.28 Intel Corporation


11.28.1 Overview


11.29 Molecular Health Gmbh


11.29.1 Overview


11.30 Precision For Medicine


11.30.1 Overview

Table 1 Leading Companies In The Precision Medicine Market 37

Table 2 Downsizing Cost Of Genome Sequencing 74

Table 3 Factors Impacting The Buyer’s Bargaining Power 80

Table 4 Factors Impacting The Supplier’s Bargaining Power 81

Table 5 Factors Impacting The Threat From Substitute 82

Table 6 Factors Impacting The Threat From New Entrant 83

Table 7 Factors Impacting The Degree Of Competition 84

Table 8 Regulatory Bodies In Precision Medicine Market 87

Table 9 Consortiums In Precision Medicine Market 93

Table 10 Alliances/Associationsin Precision Medicine Market 94

Table 11 Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) 97

Table 12 Pharma & Biotech: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) 100

Table 13 Pharma & Biotech: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Billion) 101

Table 14 Pharma & Biotech: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) 102

Table 15 Key Developments In Pharma & Biotech Companies(2015) 105

Table 16 Diagnostic Tools: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) 107

Table 17 Diagnostic Tools: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Billion) 108

Table 18 Diagnostic Tools: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) 109

Table 19 Key Developments In Diagnostic Companies(2015) 112

Table 20 Healthcare Its/Big Data: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) 113

Table 21 Healthcare Its/Big Data: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Billion) 114

Table 22 Healthcare Its/Big Data: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) 115

Table 23 Key Developments In Healthcare It/Big Data Companies(2015) 120

Table 24 Clinical Laboratories: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) 122

Table 25 Clinical Laboratories: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Billion) 123

Table 26 Clinical Laboratories: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) 124

Table 27 Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) 129

Table 28 Companion Diagnostics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 131

Table 29 Companion Diagnostics: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) 132

Table 30 List Of Approved Companion Diagnostic Devices 133

Table 31 Biomarker: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 135

Table 32 Biomarker: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) 136

Table 33 List Of Biobanks 138

Table 34 Examples Of Biobanking Initiatives Across Selected Oecd Countries 139

Table 35 Targeted Therapeutics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 142

Table 36 Targeted Therapeutics: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) 143

Table 37 Pharmacogenomics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 145

Table 38 Pharmacogenomics: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) 146

Table 39 Molecular Diagnostics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 152

Table 40 Molecular Diagnostics: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) 153

Table 41 Other Sub-Markets: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 157

Table 42 Other Sub-Markets: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) 158

Table 43 Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Billion) 163

Table 44 Cancer: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) 165

Table 45 Cancer: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) 166

Table 46 Cancer: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) 167

Table 47 Precision Medicine Drugs And Relevant Genes: Oncology 170

Table 48 Precision Medicine Genetic Tests With Respect To Oncology 171

Table 49 Key Developments (2013-2015) 172

Table 50 Cvd: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) 176

Table 51 Cvd: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) 177

Table 52 Cvd: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Million) 178

Table 53 Precision Medicine Drugs And Relevant Genes: Cardiovascular 179

Table 54 Precision Medicine Genetic Tests With Respect To Cardiovascular 180

Table 55 Key Developments (2014-2015) 181

Table 56 Cns: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 182

Table 57 Cns: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Million) 183

Table 58 Cns: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Million) 184

Table 59 Precision Medicine Drugs And Relevant Genes: Neurology 185

Table 60 Precision Medicine Drugs And Relevantgenes: Psychiatric Disorders 186

Table 61 Precision Medicine Genetic Tests With Respect To Psychiatric Disorders 187

Table 62 Psychiatric Disorders: Key Developments (2014-2015) 188

Table 63 Infectious Disease: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 189

Table 64 Infectious Disease: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Million) 190

Table 65 Infectious Disease: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Million) 191

Table 66 Precision Medicine Drugs And Relevant Genes: Infectious Diseases 192

Table 67 Other Therapeutics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 195

Table 68 Other Therapeutics: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Million) 196

Table 69 Other Therapeutics: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Million) 197

Table 70 Precision Medicine Drugs And Relevant Genes: Other Diseases 198

Table 71 Precision Medicine Genetic Tests With Respect To Other Diseases 199

Table 72 Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) 203

Table 73 Americas: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) 204

Table 74 Americas: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) 205

Table 75 Americas: Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Billion) 206

Table 76 Europe: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) 213

Table 77 Europe: Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Billion) 214

Table 78 Apac: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) 219

Table 79 Apac: Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Million) 220

Table 80 Row: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) 224

Table 81 Row: Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Million) 225

Figure 1 Precision Medicine Market Study 27

Figure 2 Research Methodology 29

Figure 3 Different Phases Of Research Methodology For The Global Market 30

Figure 4 Precision Medicine Market: Research Methodology 32

Figure 5 Global Precision Medicine Market Share, By Ecosystem, 2014-2022 ($Billion) 38

Figure 6 Global Precision Medicine Market Size, By Sub-Market Type, 2014 – 2022 (Billion) 39

Figure 7 Global Precision Medicine Market Size, By Therpeutic Application, 2014 – 2022 (Billion) 40

Figure 8 Global Precision Medicine Market Size, By Geography, 2014 – 2022 ($Billion) 41

Figure 9 Timeline Of Precision Medicine 43

Figure 10 Precision Medicine: Benefits 45

Figure 11 Examples: Applied Areas Of Precision Medicine 46

Figure 12 Elements Of Precision Medicine Technology 47

Figure 13 Different Type Of Data Used By Big Data Companies 48

Figure 14 Precision Medicine : Areas Of Interest 49

Figure 15 Precision Medicine: Partnerships, Agreements, And Collaborations (2015) 53

Figure 16 Precision Medicine : Mergers & Acquisitions( 2015) 55

Figure 17 Precision Medicine: Key Product Launch & Developments (2015) 57

Figure 18 Precision Medicine: Key Business Expansions & Contracts (2015) 58

Figure 19 Precision Medicine : Key Patents/ Approvals ( 2015) 59

Figure 20 Precision Medicine: Events & Recognition (2015) 60

Figure 21 Market Drivers And Challenges 61

Figure 22 Benefits Of Precision Medicine To Patients 63

Figure 23 Major Barriers Caused By Regulation And Standards 69

Figure 24 Flow Chart Of Precision Medicine 76

Figure 25 Precision Medicine Market: Porter Five Force Analysis 79

Figure 26 Roles And Responsibilities Of Healthcare Policy Makers 86

Figure 27 Role Of Fda In Precision Medicine 90

Figure 28 Classification Of Medical Devices 91

Figure 29 Global Precision Medicine Market By Ecosystem Players 98

Figure 30 Role Of Pharmaceuticals And Biotech Companies 103

Figure 31 Challenges Faced By Pharma & Biotech Companies 104

Figure 32 Diagnostic Tests Benefits For Stakeholders 110

Figure 33 Challenges Faced By Diagnostic Companies 111

Figure 34 Benefits Of Big Data 116

Figure 35 Transformation Of Medicine 117

Figure 36 Basic Ingredients Provided By Big Data For Precision Medicine 118

Figure 37 Challenges Faced By Big Data Companies 119

Figure 38 Oecd Recommendations On The Governance Of Clinical Trials 126

Figure 39 Types Of Precision Medicine Sub-Market 130

Figure 40 Benefits Of Companion Diagnostics 133

Figure 41 Function Of Biomarkers 137

Figure 42 Biobanks Services 141

Figure 43 Development In Pgx 147

Figure 44 Model Systems Used In Pgx 148

Figure 45 Challenges Of Pgx Studies 149

Figure 46 Figure Title Missing 154

Figure 47 Molecular Diagnostics: Application 155

Figure 48 Molecular Diagnostics: Benefits 156

Figure 49 Global Precision Medicine Market: By Therapeutics 164

Figure 50 Target Scope Of Precision Medicine By Cancer Types 169

Figure 51 Global Precision Medicine Market Classification, By Geography 202

Figure 52 Key Drivers For Precision Medicine: North America 207

Figure 53 Objectives Of The Precision Medicine Initiative 209

Figure 54 Apac: Market Challenges 221

Figure 55 Abbott: Overall Financials ($Billion), 2012-2014 228

Figure 56 Abbott: Net Revenue By Segments ($Billion), 2012-2014 228

Figure 57 Abbott: Net Revenue By Region, 2012-2014 ($Billion) 229

Figure 58 Abbott: Swot Analysis 231

Figure 59 Almac: Swot Analysis 234

Figure 60 Asuragen: Swot Analysis 237

Figure 61 Biomerieux: Overall Financials ($Million), 2012-2014 239

Figure 62 Biomerieux: Net Revenue By Region, 2014 239

Figure 63 Biomerieux: Net Revenue By Segment, 2014 240

Figure 64 Biomerieux: Swot Analysis 242

Figure 65 Cepheid: Overall Financials, 2012-2014 ($Million) 244

Figure 66 Cepheid: Net Revenue, By Segments, 2012-2014 ($Million) 245

Figure 67 Cepheid: Net Revenue, By Region, 2012-2014 ($Million) 245

Figure 68 Cepheid: Swot Analysis 247

Figure 69 Cetics Healthcare: Swot Analysis 250

Figure 70 Ge Corporation: Overall Financials, 2012-2014 ($Billion) 252

Figure 71 Ge Corporation: Net Revenue, By Segments, 2012-2014 ($Million) 253

Figure 72 Ge Corporation: Healthcare Segment, 2014 253

Figure 73 Gsk: Overall Financials, 2012-2014 ($Billion) 257

Figure 74 Gsk: Net Revenue By Segment, 2014 ($Billion) 257

Figure 75 Gsk: Net Revenue By Region, 2014 ($Billion) 258

Figure 76 Gsk: Net Revenue By Therapeutics, 2014 ($Billion) 258

Figure 77 Intomics: Swot Analysis 260

Figure 78 J&J: Overall Financials, 2012 - 2014 ($Billion) 262

Figure 79 J&J: Net Revenue By Segment, 2012 - 2014 ($Million) 262

Figure 80 J&J: Net Revenue By Region, 2012 - 2014 ($Million) 263

Figure 81 Labcorp: Overall Financials ($Million), 2012-2014 265

Figure 82 Net Revenue By Segments, 2012-2014 ($Million) 266

Figure 83 Labcorp: Swot Analysis 268

Figure 84 Medtronic: Overall Financials, 2012 - 2014 ($Million) 270

Figure 85 Novartis: Overall Financials, 2012 - 2014 ($Billion) 273

Figure 86 Novartis: Net Revenue By Region, 2014 ($Billion) 274

Figure 87 Novartis: Net Revenue By Segment, 2014 ($Billion) 274

Figure 88 Pfizer: Overall Financials, 2012 – 2014 ($Billion) 276

Figure 89 Pfizer: Net Revenue, By Segment, 2012-2014 ($Million) 276

Figure 90 Pfizer: Net Revenue, By Region, 2012-2014 ($Billion) 277

Figure 91 Pfizer: Swot Analysis 279

Figure 92 Qiagen: Overall Financials ($Million), 2012-2014 282

Figure 93 Qiagen: Net Revenue By Region ($Million), 2014 282

Figure 94 Qiagen: Net Revenue By Segment, 2014 283

Figure 95 Quest: Overall Financials, 2012 - 2014 ($Million) 285

Figure 96 Quest: Net Revenue, By Segment, 2012 - 2014 ($Million) 286

Figure 97 Quest: Swot Analysis 288

Figure 98 Randox: Swot Analysis 291

Figure 99 Roche: Overall Financials, 2012-2014 ($Billion) 293

Figure 100 Roche: Net Revenue, By Segments, 2012-2014 ($Billion) 293

Figure 101 Roche: Swot Analysis 295

Figure 102 Sanofi Pharma: Overall Financials, 2012-2014($Billion) 297

Figure 103 Sanofi Pharma: Net Revenue, By Segments, 2012-2014 ($Bilion) 297

Figure 104 Takeda: Overall Financials, 2012-2014 ($Billion) 299

Figure 105 Takeda: Swot Analysis 301

Figure 106 Teva: Overall Financials, 2012 – 2014 ($Billion) 303

Figure 107 Teva: Net Revenue Share, By Segment (2014) 303

Figure 108 Teva: Net Revenue Share, By Region (2014) 304

Figure 109 Teva: Swot Analysis 307